公开(公告)号：US09694170B2

公开(公告)日：2017-07-04

申请号：US13709429

申请日：2012-12-10

Applicant: Brainlab AG

Inventor： Christoph Pedain ,  Andreas Hartlep

IPC: A61M5/14 ,  A61M37/00 ,  A61M5/142 ,  A61B34/20

CPC classification number: A61M37/00 ,  A61B2034/2055 ,  A61M5/142 ,  A61M2005/14292 ,  A61M2210/1071

Abstract: A method for planning an infusion into hepatic tissue into a patient includes: obtaining anatomical and/or physiological patient data of the patient's liver or a region of the liver; determining at least one patient parameter from the patient data; planning the infusion using the anatomical patient data, physiological patient data, and/or at least one patient parameter, wherein planning includes determining how an administered substance is distributed in the tissue and/or how the administered substance influences physiological properties of the tissue; and determining a distribution and/or effectiveness of a therapeutic agent administered with the substance or after the substance.

公开(公告)号：US20160015951A9

公开(公告)日：2016-01-21

申请号：US13709429

申请日：2012-12-10

Applicant: Brainlab AG

Inventor： Christoph Pedain ,  Andreas Hartlep

IPC: A61M37/00

CPC classification number: A61M37/00 ,  A61B2034/2055 ,  A61M5/142 ,  A61M2005/14292 ,  A61M2210/1071

Abstract: A method for planning an infusion into hepatic tissue into a patient includes: obtaining anatomical and/or physiological patient data of the patient's liver or a region of the liver; determining at least one patient parameter from the patient data; planning the infusion using the anatomical patient data, physiological patient data, and/or at least one patient parameter, wherein planning includes determining how an administered substance is distributed in the tissue and/or how the administered substance influences physiological properties of the tissue; and determining a distribution and/or effectiveness of a therapeutic agent administered with the substance or after the substance.

Abstract translation: 一种用于规划将肝组织输注入患者的方法包括：获得患者肝脏或肝脏区域的解剖学和/或生理学患者数据; 从所述患者数据确定至少一个患者参数; 使用解剖患者数据，生理学患者数据和/或至少一个患者参数来计划输注，其中规划包括确定给药物质如何分布在组织中和/或所施用的物质如何影响组织的生理特性; 以及确定施用该物质或物质后的治疗剂的分布和/或有效性。